Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial

BACKGROUND: Despite the reported success in reducing morbidity, praziquantel alone is insufficient for the control and elimination of schistosomiasis, partly due to its poor efficacy against the juvenile worms. Artemisinin derivatives are effective against juvenile worms but are less effective again...

Descripción completa

Detalles Bibliográficos
Autores principales: Mnkugwe, Rajabu Hussein, Minzi, Omary, Kinung’hi, Safari, Kamuhabwa, Appolinary, Aklillu, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510991/
https://www.ncbi.nlm.nih.gov/pubmed/32966290
http://dx.doi.org/10.1371/journal.pntd.0008619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510991/
https://www.ncbi.nlm.nih.gov/pubmed/32966290
http://dx.doi.org/10.1371/journal.pntd.0008619

Ejemplares similares